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TD-60 links RalA GTPase function to the CPC
in mitosis
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TD-60 (also known as RCC2) is a highly conserved protein that structurally resembles the
Ran guanine exchange factor (GEF) RCC1, but has not previously been shown to have GEF
activity. TD-60 has a typical chromosomal passenger complex (CPC) distribution in mitotic
cells, but associates with integrin complexes and is involved in cell motility during interphase.
Here we show that TD-60 exhibits GEF activity, in vitro and in cells, for the small GTPase
RalA. TD-60 or RalA depletion causes spindle abnormalities in prometaphase associated with
abnormal centromeric accumulation of CPC components. TD-60 and RalA apparently work
together to contribute to the regulation of kinetochore–microtubule interactions in early
mitosis. Importantly, several mitotic phenotypes caused by TD-60 depletion are reverted by
the expression of a GTP-locked mutant, RalA (Q72L). The demonstration that a small GTPase
participates in the regulation of the CPC reveals a level of mitotic regulation not suspected in
previous studies.
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D-60 (Telophase Disk-60), also known as RCC2, was
originally identified using a human autoimmune serum
that stained the anaphase spindle midzone1. This staining
resembled that seen for the chromosomal passenger complex
(CPC), a major regulator of mitosis2, which was originally defined
based on its movement from inner centromeres in early mitosis to
the spindle midzone and midbody during mitotic exit3.
The CPC is composed of Aurora B kinase4 plus an activation/
targeting module consisting of inner centromere protein
INCENP3, Survivin and Borealin/Dasra B5,6. The complex
regulates key aspects of mitosis, including chromosome and
spindle structure, the correction of kinetochore–microtubule
attachment errors, the spindle assembly checkpoint and
cytokinesis2. Depletion of any CPC component induces
delocalization of the others and disrupts mitotic progression5,7–9.
Although TD-60 is not a member of the core CPC, it becomes
mislocalized if CPC components are suppressed in mammalian
cells5. Similarly, TD-60 knockdown perturbs the localization of
other CPC members10,11. Furthermore, it shares a characteristic
phospho-epitope with INCENP and Aurora B12. In Xenopus
Laevis extracts, TD-60 depletion does not affect CPC centromeric
localization, but Aurora B kinase activity is compromised11.
TD-60 binds microtubules10, and can stimulate Aurora B kinase
activity in the presence of microtubules in vitro11.
Cloning revealed TD-60 to be related to RCC1 (regulator of
chromatin condensation 1)10, a guanine exchange factor (GEF)
for the small GTPase Ran13. This led to the protein being
annotated as RCC2 in databases. TD-60 binds the nucleotide-free
form of Rac1 in vitro, and was suggested to be a Rac1 GEF10.
TD-60/RCC2 has also been identified in studies looking at
cellular migration. It is found in pull downs of a5b1-fibronectin
complexes at nodes of the interactome near Rac1, which controls
cell protrusions, and Arf6, a regulator of membrane trafficking14.
This confirmed a previous proteomic study that also found an
interaction between TD-60 and Arf6 (ref. 15). The later study
concluded that TD-60 is required for certain types of cellular
motility, but that it does so by limiting the activity of Rac1 and
Arf6, rather than acting as a GEF14. TD-60/RCC2 also co-
immunoprecipitates with the regulator of actin filament assembly
cortactin16. The functional significance of these interactions is not
known but TD-60/RCC2, Arf6 and cortactin have all been
associated with tumour invasiveness and metastasis in
melanoma17,18 and other cancers19,20.
Here, we show that TD-60 is a GEF, with an unexpected
substrate—the small Ras-like GTPase RalA. RalA is thought to
cooperate with Arf6 in the activation of phospholipase D21, and is
also thought to have a role in oncogenesis17,22–24. We report that
TD-60 has GEF activity towards RalA in vitro and in cells;
that cells depleted of TD-60 or RalA show similar mitotic
phenotypes including perturbed spindles, higher microtubule
density at kinetochores and increased inter-kinetochore stretch;
and that this corresponds with decreased Aurora B activity at
prometaphase centromeres. Importantly, wild-type (WT) Aurora
B activity could be restored in cells lacking TD-60 by expressing
the constitutively active GTP-locked RalA mutant Q72L. Our
study links TD-60 activation of RalA with the CPC in regulating
kinetochore–microtubule interactions in early mitosis.
Results
TD-60 is a RalA GEF. TD-60 is a highly conserved protein that
shares sequence similarity with RCC1 (ref. 10), particularly
between amino-acid residues 100 and 500, which consist almost
entirely of seven RCC1 motifs (Fig. 1a and Supplementary
Fig. 1a). Because RCC1 is a GEF for the small GTPase Ran25,26,
it was initially assumed that TD-60 would exhibit GEF activity,
possibly for Rac1 (ref. 10). However, previous studies failed to
demonstrate this GEF activity.
To characterize TD-60-associated GEF activity in vitro, we
expressed human TD-60 containing an amino-terminal strepta-
vidin-binding protein (SBP) tag in Sf9 cells. Cloning and
expression of the human TD-60 cDNA was only possible
following the replacement of a 50 low complexity region of
B250 bp that is unstable in E. coli (Supplementary Fig. 1b–d)
with a sequence that was codon optimized for baculovirus
expression (Supplementary Fig. 1e).
Purified SBP-TD-60 was tested for GEF activity using a
GDP-release assay against a broad selection of highly purified
human GTPase targets representing all GTPase superfamilies
(Supplementary Fig. 2a)27,28. We have used this end-point assay
in a number of previous studies to directly compare the GEF
activity of a candidate regulatory factor against a panel of
different GTPases under the same experimental conditions27,29.
The purification of the GTPases and the assay itself have been
described in detail30. The well-characterized GEF Rabex5, and its
substrate, the GTPase Rab5a31, provided a positive control for
GEF activity. This GEF/substrate pair catalysed the release of
15 pmol GDP under the standardized conditions used (Fig. 1b).
Unexpectedly, TD-60 displayed consistent high GEF activity
(12.5 pmol GDP released) for the Ras-related protein RalA32,33
(Fig. 1b). This was not statistically different from the activity of
Rabex5 towards Rab5A (P¼ 0.0578; Student’s t-test). In contrast,
TD-60 exhibited little activity for expected targets from the Rho
GTPase superfamily10, including Rac1 (for example, comparison
of the Rac1 measurement versus that for RalA yielded a
P¼ 0.0041; Student’s t-test; Fig. 1b and Supplementary
Table 1). Despite its similarity to RCC1, TD-60 showed no
activity towards Ran (comparison against the value for RalA
yielded a Po0.0001).
An explanation for the latter result is readily apparent when
one examines the electrostatic surface potential for the interface
between RCC1 and Ran. We calculated a predicted TD-60
structure using the Phyre2 Server34, and superimposed this onto
the RCC1 crystal structure (PDB id: 1I2M—Fig. 1c). TD-60 is
predicted with a high level of confidence to be structurally
extremely similar to RCC1, with the exception of an alpha-helical
segment that is exclusive to vertebrate TD-60 (arrows, Fig. 1c)10.
The Ran-binding region of RCC1 is predominantly negatively
charged and this binds to a highly positively charged surface of
Ran (Fig. 1d). In marked contrast, the corresponding surface of
the TD-60 model is positively charged and could potentially dock
with a negatively charged ridge on RalA (arrow, Fig. 1e).
Although GEFs, as enzymes, typically exhibit transient low-
affinity interactions with their substrates, we were able to confirm
the physical interaction between TD-60 and RalA in vitro. We did
this by far-western analysis, in which purified RalA bound to
purified TD-60 (Supplementary Fig. 2b). In a parallel control
experiment, purified Ran did not bind to TD-60 (Supplementary
Fig. 2b). To determine if TD-60 could interact with RalA also in
cells, we immunoprecipitated endogenous TD-60 from HeLa
cells transfected with green fluorescent protein (GFP)-tagged
RalA WT, or the two mutants, RalA G26A (GDP-locked) or
Q72L (GTP-locked). As detected by immunoblotting, TD-60 co-
immunoprecipitated with the RalA G26A mutant (GDP-locked;
Fig. 1f). A similar result was obtained in an independent repeat of
this experiment (Supplementary Fig. 2d).
In addition, when we measured RalA-GTP levels in cells
using a specific RalA effector protein-binding assay, cells lacking
TD-60 showed a statistically significant decrease in RalA-GTP
(P¼ 0.0369, Student’s t-test) versus control short interfering
RNA (siRNA) cells (Fig. 1g). We conclude that, like RCC1, with
which it shares sequence and likely structural similarity, TD-60 is
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Figure 1 | TD-60 has GEF activity towards RalA. (a) Schematic diagram of the human TD-60 protein showing RCC1 motif distribution. (b) Human TD-60
was tested against a representative panel of human small GTPase proteins using a published GDP-release assay30,70. Nucleotide exchange was calculated
as pmoles of GDP released (n¼ 2,4). Graph reports mean±s.e.m. Statistical significance was determined using unpaired Student’s t-test (***Po0.0001).
Additional statistical values can be found in Supplementary Table 1 (c) Superposition of a TD-60 structure (grey) predicted using Phyre2 (http://
www.sbg.bio.ic.ac.uk/phyre2)34, onto the crystal structure of RCC1 (pink—PDB id: 1I2M) suggests that the overall structure of TD-60 is similar to RCC1
with an insertion of an a-helical segment (highlighted by arrows) which is unique to higher vertebrate TD-60. (d) Surface representation of RCC1 and Ran
highlighting the charge complementarity of their binding interfaces (both shown facing the viewer, such that a 180 flip of one of the binding partners brings
the two interacting surfaces together). Blue and red represent positive and negatively charged regions, respectively. Electrostatic surface potential of RCC1
and Ran (PDB id: 1I2M) was calculated using the APBS plug-in in PyMOL (The PyMOL Molecular Graphics System, Version 1.5.0.4 Schro¨dinger, LLC).
(e) Similar analysis of surface charge for TD-60 and RalA (PDB id: 2A78). (f) Pull-down assay reveals that TD-60 interacts specifically with RalA when
bound to GDP in cells. HeLa Kyoto cells were transfected to express GFP-tagged RalA WT, G26A (GDP) and Q72L (GTP), and endogenous TD-60 was
pulled down using GFP-Trap-M beads. (g) TD-60 depletion reduces RalA activation in cells. HeLa cells were transfected with TD-60 siRNA and RalA-GTP
levels in lysates were measured by G-LISA assay. Graph reports the mean absorbance at 490nm±s.e.m. (n¼ 3), with statistical significance assessed
using unpaired Student’s t-test (*Po0.05).
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indeed a GEF, but for RalA and not for Ran or Rho family
members.
TD-60 depletion perturbs spindles and centromeric Aurora B.
TD-60 got its name from the characteristic staining of the
anaphase spindle midzone observed using a human autoantibody1.
That staining resembled the characteristic CPC localization3,
however, TD-60 does not co-immunoprecipitate with the CPC,
even though immunostaining experiments suggest some functional
link with the complex5,10. In support of the conclusion that TD-60
is not a component of the CPC in vivo, perturbation of mitotic
chromosome structure often produces very different effects on the
CPC and TD-60. For example, depletion of the chromokinesin
KIF4A causes a modest, but reproducible, decrease in
chromosomal levels of the four core CPC subunits, whereas the
levels of TD-60 show a significant increase (Supplementary
Fig. 2e). We have shown previously that the individual subunits
of protein complexes typically co-vary in this analysis35.
We used RNA interference (RNAi) to examine the role of
TD-60 in mitosis in HeLa cells. TD-60 protein was significantly
depleted in HeLa cells 48 h after transfection with two
published TD-60-specific siRNAs (Fig. 2a)10. We observed a
higher frequency of prophase and prometaphase cells in
TD-60-depleted samples (Fig. 2b, Supplementary Fig. 3a). These
results contrast with a published report in which TD-60 depletion
was reported to cause a strong arrest of cells in prometaphase10.
Importantly, in that study, cells were examined mainly during
recovery from 16 h of nocodazole treatment. A more recent study
from that group has reported that the depletion of TD-60 causes a
decrease in mitotic entry36. In our study, the siRNAs were added
to asynchronous cultures allowing us to follow unperturbed entry
into and passage through mitosis.
The increase in cells in early mitosis following TD-60 depletion
was counterbalanced by a decrease in cells in telophase and
cytokinesis (Supplementary Fig. 3a). Thus, after an initial delay,
TD-60-depleted cells are apparently able to exit mitosis with
normal, or even slightly elevated, kinetics.
This result was confirmed by live-cell imaging in U2OS cell
lines, which revealed a modest, but statistically significant, delay
of anaphase onset in TD-60-depleted cells (Supplementary
Fig. 3b–d). Closer examination of fixed cells revealed that the
delay in early mitosis correlated with a significant increase in the
proportion of prometaphase cells with early prometaphase-like
abnormal spindle shapes (Fig. 2c,d and Supplementary Figs 3e
and 4a).
TD-60-depleted cells also exhibited an increased level of
Aurora B staining at centromeres relative to control cells. Staining
was scored for each centromere relative to the level of ACA
staining for kinetochore proteins (Fig. 2e,f and Supplementary
Fig. 4b). The increase in Aurora B levels at centromeres following
TD-60 depletion was statistically significant (Fig. 2f). Survivin and
INCENP levels also increased at centromeres following TD-60
depletion (Supplementary Fig. 4c); however, the levels of total
histone H3 Serine 10 phosphorylation (H3S10ph) and H3 Serine
28 phosphorylation (H3S28ph) were not significantly altered
(Supplementary Fig. 4e).
Given the functional connection observed between TD-60 and
RalA in vitro, we also asked whether TD-60 depletion altered the
subcellular distribution of RalA. The distribution of RalA in cells
was typically diffuse/punctate, although in many cells the protein
was concentrated near the plasma membrane and in telophase
cells, some RalA was also observed in the intercellular bridge
(Supplementary Fig. 4d). TD-60 was not required for RalA
localization at the plasma membrane or in the cytoplasm
consistent with the view that RalA is regulated by other GEFs
at these sites37.
We conclude that TD-60 function in early mitosis is important
for spindle assembly and regulation of the levels of the CPC at
centromeres.
RalA depletion perturbs spindles and centromeric Aurora B.
RalA regulates vesicle trafficking, filopodia formation and
cytoskeleton remodelling24. More recently, RalA has been shown
to be required for segregation of the mitochondrial network
during mitosis in a pathway that requires both cyclin B–Cdk1 and
Aurora A kinase activity38.
To further explore the functional interactions between TD-60
and RalA, we examined the mitotic phenotype following the
suppression of RalA expression in HeLa cells. Immunoblotting
showed that RalA was significantly depleted in asynchronous
HeLa cultures treated with RalA-specific siRNAs (Fig. 3a)39.
As was seen following TD-60 suppression, a modest increase in
the percentage of cells in early mitosis was seen after 72 h of
exposure to RalA siRNA (Fig. 3b). Indirect immunofluorescence
confirmed the effectiveness of the RNAi, as cells transfected with
RalA siRNA lacked detectable RalA at the plasma membrane and
in the cytoplasm during mitosis (Fig. 3c,d).
RalA depletion resulted in phenotypes similar to those seen
following depletion of TD-60. We observed both an increase in
early prometaphase-like and abnormal mitotic spindle shapes
resembling those seen following TD-60 depletion (Supplementary
Fig. 5) and an accumulation of Aurora B at centromeres (Fig. 3c,d).
The increase in centromeric levels of Aurora B relative to ACA
after RalA ablation was statistically significant (Fig. 3e).
Together these results suggest that TD-60 and RalA might act
in a common pathway to control spindle assembly and CPC
distribution in mitosis.
Loss of TD-60 or RalA raises prometaphase Kt-fibre stability.
The abnormal spindle phenotype observed in TD-60 and
RalA-depleted cells suggested that kinetochore–microtubule
interactions might be altered in those cells. To test this
hypothesis, cells transfected with TD-60 or RalA-specific siRNAs
were cold treated and Kt-fibres (microtubule bundles attached
to kinetochores) in prometaphase visualized by indirect
immunofluorescence. Kinetochores were localized by CENP-C
staining, and we then measured the tubulin staining intensity
adjacent to them using a custom kinetochore-recognition macro
in ImageJ40. A modest but statistically significant increase
in kinetochore-associated cold-stable tubulin was observed
following either TD-60 or RalA depletion (Fig. 4a–e)
We conclude that both TD-60 and RalA are required for
prometaphase kinetochores to make normal and cold-stable
attachments to microtubules.
RalA Q72L rescues mitotic defects caused by TD-60 depletion.
The similar phenotypes observed following the knockdown of
both TD-60 and RalA led us to hypothesize that TD-60 activation
of RalA might be required to regulate kinetochore–microtubule
interactions in early mitosis. To test this hypothesis, we asked
whether a constitutively active RalA mutant (RalA Q72L—the
GTP-locked form) could rescue the phenotypes observed
following transfection of HeLa cells with TD-60 siRNAs.
Interestingly, expression of RalA Q72L in cells transfected with
TD-60 siRNA restored WT Kt-fibre MT density in prometaphase
HeLa cells as determined using the cold-stable microtubule assay
(Fig. 4f), and appeared to rescue the prometaphase delay (Fig. 5a)
and the excess accumulation of Aurora B at centromeres
normally observed following TD-60 depletion (Fig. 5b,c). These
experiments further confirm a functional interaction between
TD-60 and RalA in vivo.
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TD-60 depletion reduces Aurora B activity in prometaphase.
As shown here, prometaphase cells depleted of TD-60 or RalA
exhibit both increased levels of centromere-associated CPC and
microtubule density at kinetochores. These two observations
could be reconciled if the phosphorylation of Hec1/Ndc80 on
Ser44 by Aurora B, which regulates the affinity of the kinetochore
for microtubules, was perturbed in TD-60-depleted cells41–43.
Indeed, we did observe a statistically significant decrease in the
levels of Hec1 phosphorylation in prometaphase cells, while there
was a slight increase in metaphase cells (Fig. 5d,e). This would be
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Figure 2 | TD-60 siRNA perturbs prometaphase spindles and centromeric Aurora B. (a) Immunoblots of whole HeLa cell extract (WCE) transfected with
siRNAs targeting two different regions of human TD-60. Immunoblot for RCC2 (TD-60) and RalA, with b-actin as a loading control. (b) Mitotic index of
TD-60-depleted cells 48 h after transfection with siRNA is increased from prophase to metaphase. Graphs report the mean±s.e.m. (n¼4). (c) Control
and TD-60-depleted cells fixed with 4% PFA were stained with DAPI (blue), a-tubulin (red) and aurora B (green). Scale bar, 10mm. (d) The proportion of
prometaphase cells with abnormal spindle shapes (in which the poles were partly separated but nascent spindles were confined within the regions
containing chromosomes) in TD-60-depleted and control cultures was determined by a blinded observer (n¼4). In this and all subsequent figures, graphs
report the mean±s.e.m., with statistical significance assessed using the Mann–Whitney U-test (*Po0.05). (e) Both prometaphase and metaphase cells
show an increased level of centromeric Aurora B after 48 h TD-60 depletion. TD-60-depleted cells were fixed with 4% PFA and stained with DAPI (blue),
ACA (red) and Aurora B (green). Scale bar, 10mm. (f) Quantification of Aurora B intensity from the experiment illustrated in e using ImageJ and normalized
to the ACA control (n¼ 15, **Po0.005 by Mann–Whitney U-test). More information regarding quantification can be found in Supplementary Fig. 4b. DAPI,
40,6-diamidino-2-phenylindole.
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expected to stabilize microtubule attachments in prometaphase
and therefore perhaps to slow the recovery of TD-60 and RalA-
depleted cells from a block with the Eg5 inhibitor monastrol44.
Indeed, although TD-60 or RalA-depleted cells could recover
from such a block and form normal bipolar spindles, the process
did appear to be slightly delayed (Supplementary Fig. 6).
A decrease in Hec1Ser44ph at kinetochores would be expected
to be associated with more robust kinetochore–microtubule
attachments, as conventionally detected in ‘kinetochore stretch’
assays (Fig. 6a). We therefore measured the kinetochore stretch
of prometaphase and metaphase chromosomes in control
and TD-60-depleted cells. Consistent with the MT density and
Hec1S44ph measurements, we observed a greater inter-
kinetochore stretch in prometaphase cells depleted of TD-60
(Fig. 6b). Importantly, this increased tension at prometaphase
kinetochores is apparently due to the loss of TD-60’s GEF activity
for RalA, since the expression of RalA Q72L in TD-60-depleted
cells restored the sister-kinetochore spacing to WT values
(Fig. 6b).
It was not initially obvious how the increase in Aurora B levels
at centromeres seen after TD-60 or RalA depletion would result
in the apparent decrease in Aurora B activity at prometaphase
kinetochores observed in the Hec1 phosphorylation and
kinetochore stretch assays. We therefore measured a direct
marker of Aurora B activity status—autophosphorylation of
Thr232 in the ‘activation loop’ of the kinase—using a validated
phospho-specific antibody45. Quantification of Aurora B-T232ph
levels adjacent to ACA (using a custom kinetochore-recognition
macro in ImageJ40) revealed that centromeric Aurora B appeared
to be significantly less active in prometaphase (Fig. 6c,d). The
levels of active kinase were also diminished in metaphase, though
to a lesser degree.
As a control for the experiments in which RalA Q72L was
shown to reverse the effects of TD-60 depletion, we expressed
both RalA WT and RalA Q72L in HeLa cells and measured the
inter-kinetochore distance in both prometaphase and metaphase
cells. Minimal differences were seen when we compared
transfected and untransfected cells, with a slight decrease seen
in prometaphase cells expressing RalAQ72L and a slight increase
seen in metaphase cells expressing RalA WT (Supplementary
Fig. 7). In all cases, the changes were far less than those observed
in the RNAi-rescue experiments.
As summarized in Fig. 6e, these results suggest that
TD-60-associated RalA GEF activity contributes to regulation of
kinetochore–microtubule stability in prometaphase, both by
regulating CPC levels and activity at centromeres.
Discussion
The reported localization of TD-60 to centromeres, the spindle
midzone (the ‘Telophase Disk’) and midbody resembles that of
the CPC1,2 and TD-60 has been proposed to be either a
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2-phenylindole.
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component of the CPC or functionally closely associated with
it5,10,11. The experiments reported here reveal that TD-60,
through its action as a GEF for RalA, does influence the
localization and activity of the CPC at centromeres during early
mitosis. Thus, TD-60 apparently functions in conjunction with
the CPC, but not as a part of the complex itself.
Other studies have found links between TD-60/RCC2
and cell migration, membrane trafficking and cancer cell
invasiveness14,16,17. These roles for the protein appeared at
odds with its presumed mitotic functions, but now fit very well
with our discovery that TD-60 is a bona fide GEF for RalA. RalA
is involved in membrane trafficking, regulation of cell shape and
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movement, cytokinesis and anchorage-independent growth of
transformed cells21,24. RalA effectors that bind activated RalA
include RalBP1 and the exocyst46. RalA also interacts in a GTP-
independent manner with calmodulin and is involved, with Arf6,
in the activation of phospholipase D21. In these non-mitotic roles,
TD-60 and RalA appear to share a number of interacting partners
and functional roles. It is noteworthy, given the links between
RalA and cancer, that the TD-60/RCC2 gene shows reduced copy
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number in 433% of breast, colon, lung and ovarian cancers
catalogued in the COSMIC database47. Furthermore, that
database shows that several residues located on the predicted
RalA-binding surface of TD-60 can undergo missense mutations
in cancer.
We find that TD-60 has GEF activity for RalA, but not for RalB
(or Rac1 or Ran). This distinction is not unexpected. RalA and
RalB share 80% sequence identity, but whereas RalA is
dispensable for life in HeLa cells, RalB is essential22.
Furthermore, RalA and RalB function at distinct stages of
cytokinesis and may be activated by different GEFs48. Moreover,
electrostatic surface potential calculations also highlight
noticeable differences between RalA and RalB in their putative
TD-60-binding surfaces (Supplementary Fig. 8a). A closer look at
the amino-acid composition of their TD-60-binding interfaces
also shows the presence of at least three variations
(Supplementary Fig. 8b) that might explain the RalA-specific
activity shown by TD-60.
The role of RalA in mitotic regulation has been less widely
studied than those of Rac, RhoA and Cdc42. Together with the
exocyst, RalA has a role in cytokinesis, although the exact details
of this are disputed39,48. More recent studies have revealed that
RalA activated by Aurora A kinase phosphorylation23,49 relocates
to mitochondrial membranes in metaphase24. There it acts
together with cyclin B/Cdk1 to regulate mitochondrial fission via
targeting of the GTPase Drp1 (refs 38,50).
Our studies reveal that TD-60 and RalA—likely acting at least
in part via the CPC—modulate kinetochore–microtubule inter-
actions during mitosis (Fig. 6f). Perhaps surprisingly, despite our
data clearly revealing a number of functional connections
between RalA activation and kinetochore function, antibody
staining did not reveal a concentration of RalA near centromeres.
We propose that RalA may function in mitosis like Ran—by
forming gradients of activity near its sites of action that are
created through the localization of its relevant GEF51,52. Thus,
much as Ran is activated in a gradient close to mitotic
chromosomes where its GEF RCC1 binds53,54, RalA may be
activated near centromeres as a result of the localization of
TD-60. It will be interesting in future experiments to map the
distribution of active RalA in mitotic cells, as has been done for
Ran, though this is likely to be complicated, given that there are at
least six other GEFs for RalA.
A major function of the CPC during prometaphase is to
regulate the microtubule binding affinity of the kinetochore55,56.
It does this by phosphorylating outer kinetochore proteins such
as Ndc80/Hec1 and the Knl1 complex41,42,57,58. This reduces
their affinity for microtubules and promotes microtubule release,
thereby allowing error correction. Our results now add TD-60/
RalA as an additional control input to this important process.
In prometaphase, TD-60/RalA appears to promote dynamic
interactions between kinetochores and microtubules. Thus, on
TD-60 depletion, spindle tension (measured by sister-kinetochore
stretch) and Kt-MT density are increased, recovery from a
monastrol block is delayed, and prometaphase spindle structure is
abnormal. These effects apparently depend on the GEF activity of
TD-60 for RalA, since they can be reversed by the expression of
RalA Q72L, and may at least be partly explained by a decrease in
the phosphorylation of Hec1Ser44 by Aurora B. The continued
ability of TD-60/RalA-depleted cells to form Kt-MT attachments
might explain why these cells are, after a delay, apparently able to
satisfy the mitotic checkpoint and exit mitosis.
These results are particularly interesting in view of a recent
study that described a significant difference in the dynamics of
kinetochore–microtubule interactions between prometaphase
and metaphase59. The authors argued that this difference
(more dynamic interactions in prometaphase versus more static
interactions in metaphase) was due to the activity of
Cdk1–cyclin A, with the prometaphase/metaphase switch
requiring destruction of cyclin A by the proteasome.
Considering their results together with ours, it is interesting to
speculate that Cdk1–cyclin A might directly or indirectly activate
the relevant GEF activity of TD-60. Alternatively, RalA-GTP
might function in a signalling pathway alongside Cdk1–cyclin A,
much as it does with Cdk1–cyclin B in mitochondrial segregation.
This study provides the first example of a functional interaction
between a small GTPase and the CPC in mitotic regulation. The
mechanisms by which RalA regulates CPC level and activity at
the centromere remain to be determined, and in the future it will
be important to determine whether RalA impacts on the various
systems that target the CPC to centromeres60–62 or on systems
that remove the CPC from chromatin63,64, as well as on
CPC-independent regulatory mechanisms in mitosis and beyond.
Methods
Cell culture. HeLa Kyoto (EMBL Heidelberg, Germany), U2OS EGFP-g-tubulin/
mRFP-H2B65 and U2OS GFP-a-tubulin cells (a gift from Duane Compton,
Dartmouth, USA) were grown in Dulbecco’s modified Eagle’s Medium
supplemented with 5% (v/v) FBS (fetal bovine serum) and 100Uml 1
penicillin–streptomycin, at 37 C and 5% CO2 in a humidified incubator.
Plasmids. Human SBP-TD-60 was codon optimized, synthetically generated and
subcloned in pFastBacI by GeneArt. The human RalA Q72L mutant was generated
by site-directed mutagenesis using (FW 50-agatacagctgggctggaggactacgctg-30 ; RV
50-cagcgtagtcctccagcccagctgtatct-30) and RalA G26A mutant was generated by
site-directed mutagenesis using (FW 50-agtggtggcgtggccaagtcagctctg-30 ; RV 50-cag
agctgacttggccacgccaccact-30). RalA WT was used as a DNA template. Mutants
generation was performed according to standard protocols using a Stratagene
QuickChange II XL. RalA Q72L was cloned into pTRACER_SV40 (Life
Technologies). For pull-down assays, human RalA WT, G26A and Q72L were
cloned into pEGFP-C2 (Clontech). For far-western assay human RalA and Ran
were cloned into pFAT2.
Antibodies. For immunofluorescence analysis, we used the following primary
antibodies: anti-Aurora B rabbit polyclonal antibody (Abcam ab2254, 1:1,000),
anti-AIM-1 mouse monoclonal antibody (BD Bioscience 611,082, 1:100), anti-
Tubulin B512 mouse monoclonal antibody (Sigma T5168, 1:1,000), anti-INCENP
P240 rabbit polyclonal antibody (Cell Signalling 2,807, 1:400), anti-Survivin
rabbit polyclonal antibody (Novus Biological NB500-201, 1:200), anti-H3S10ph
rabbit polyclonal antibody (Merck Millipore 06-570, 1:500), anti-H3S28ph rabbit
polyclonal antibody (Cell Signalling 9,713, 1:200), anti-RalA mouse monoclonal
antibody (BD Bioscience 611,022, 1:50), anti-Hec1S44ph rabbit polyclonal anti-
body (kindly supplied by Dr Jennifer DeLuca43), anti-CENP-C rabbit polyclonal
antibody66, anti-Aurora B-T232ph rabbit polyclonal antibody45 and anti-ACA
human serum67. For secondary incubations, we used antibodies conjugated with
Alexa (Life Technologies) Fluor 594 (rabbit a21207 and mouse a21203, 1:1,000),
Fluor 488 (rabbit a21206 and mouse a21202, 1:500) and Flour 647 (rabbit
a31573 and mouse a31571, 1:250) and anti-human Alexa Fluor 647 (Jackson
Immunoresearch 709-605-149, 1:250 )
RNA interference. For both TD-60 and RalA depletion, 0.8 105cellsml 1 of a
logarithmically growing HeLa culture were transfected with target specific siRNA
duplexes39, using HiPerfect transfection reagent (QIAGEN) according to the
manufacturer’s protocol. A control siRNA (QIAGEN) that shows no homology to
any known mammalian gene was used as a negative control.
HeLa cells were transfected with 150 nM of TD-60 siRNAs covering two
separate regions (siRNA_1:1500.aagagatgaaagtgagactga1520; siRNA_2:
535aaggggcagctgggacatggt555) for 48 h (ref. 10).
HeLa cells were transfected with 50 nM of RalA siRNAs covering two separate
regions (siRNA_1: 17 ccaagggtcagaattcttt36; siRNA_2: 484 gctaatgttgacaaggtat503 )
for 72 h (ref. 39).
For TD-60 siRNA rescue experiments, HeLa cells were co-transfected with
150 nM of TD-60 siRNA (siRNA_2) plus 6 mg DNA encoding RalA
Q72LpTRACER using PolyPlus transfection reagent (JetPRIME) according to
the manufacturer’s protocol.
Indirect immunofluorescence. HeLa cells were grown on polylysine-coated
coverslips (Poly-L-lysine solution—SIGMA) and fixed respectively with
paraformaldehyde (PFA) or ice-cold methanol (MeOH). For PFA fixation, cells
were fixed for 10min with 4% (v/v) paraformaldehyde (Electron Microscopy
Services) in warm 1 buffer PBS. Cells were permeabilized with 0.15%
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Triton-X-100 in 1 PBS for 2min at room temperature. After permeabilization,
coverslips were incubated with 1% (v/v) bovine serum albumin/PBS blocking
solution for an hour at room temperature. For MeOH fixation, cells were fixed for
10min with ice-cold methanol and then washed in PBS 1 . Fixed cells were then
stained with specific antibodies.
Cold-stable microtubule assay. Transfected cells were incubated with ice-cold
Dulbecco’s modified Eagle’s Medium for 10min, followed by 2min with PHEM
buffer pH 6.9 (60mM PIPES, 25mM HEPES, 10mM EGTA, 2mM MgCl2), and
fixed in ice-cold MeOH for 2min. Cells were stained with specific antibodies as
described above.
Imaging. Three-dimensional data sets were acquired using a CoolSnap HQ cooled
CCD camera (Photometrics), on a DeltaVision Spectris microscope (Applied
Precision, LLC, WA) with a  100/1.4NA PlanApo lens. Optical sections were
acquired every 0.2 mm, and three-dimensional data sets were deconvolved using the
constrained iterative algorithm68,69.
Live-cell imaging were conducted using a Nikon Ti-E inverted microscope with
a  20/0.75 NA objective. Images were acquired using Nikon DS Qi1MC camera
with a resolution of 1,024 1,024 pixels, every 5min for 22 h in a 5% CO2/37 C
chamber.
Cold-stable microtubules, Hec1S44ph and Aurora B-T232ph were quantified
using a macro based on the default setting for CraQcode v1.06 (ref. 40) as modified
in the Earnshaw lab by Nuno Martins. This macro uses ACA to detect
kinetochores, and then draws a box around the centromere to define a region for
quantification of the data channel. The Aurora B level in TD-60 and RalA siRNA
experiments was quantified using ImageJ, using ACA (Cy5) as a reference.
Intensity values of B20 cells were exported in Excel, which was also used to
calculate the Aurora B/ACA ratio (see Supplementary Fig. 4b). Inter-kinetochore
distances between sister kinetochores as detected by ACA staining were measured
in ImageJ. Classification of mitotic stages and spindle phenotypes was carried out
by a blinded observer. For statistical analysis and graphic representation, we used
Prism 5 (Graphpad). For statistical analysis of the data, we used an unpaired
Student’s t-test (***Po0.0001) or Mann–Whitney U-test (*Po0.05; **Po0.005;
***Po0.0001).
Immunoblotting. Whole-cell extracts were prepared from HeLa cells transfected
with control siRNA, TD-60 siRNA or RalA siRNA. Immunoblotting analysis was
performed using the following primary antibodies: anti-RCC2 rabbit polyclonal
antibody (Cell Signalling 1:100–1:200), anti-RalA mouse monoclonal antibody (BD
Bioscience 1:100), anti-Ran mouse monoclonal antibody (BD Bioscience 1:1,000),
anti-Tubulin B512 mouse monoclonal antibody (Sigma 1:10,000), anti-Beta Actin
mouse monoclonal antibody (Sigma 1:1,000) and anti-GFP rabbit polyclonal (Life
Technology, 1 mgml 1). For protein detection and quantitation, we used donkey
IRDye 800 secondary antibodies (LI-COR Bioscience 1:10,000), HRP-conjugated
anti-mouse secondary antibody (GE Amersham 1:5,000) and anti-rabbit IgG,
HRP-linked Antibody (Cell Signalling 1:3,000). Uncropped versions of western
blots can be found in Supplementary Fig. 9.
GFP pull-down assay. HeLa Kyoto cells were grown in 10-cm dishes and
transfected with RalA WT, G26A and Q72L in pEGFP-C2 and then incubated
for 48 h at 37 C. pEGFP-C2 empty plasmid was used as a GFP control. GFP
pull-down assays were performed by using GFP-Trap-M (GFP-binding) magnetic
beads (Chromotek) according to the manufacturer’s protocol. The lysis buffer used
was 50mM Tris pH 8.0, 0.4M NaCl, 0.5% NP-40, 0.5% deoxycholate, 1:1,000
protease inhibitor cocktail P-8340 (Sigma) and 100mM PMSF. The dilution buffer
was 50mM Tris pH 8.0, 0.4M NaCl, 0.1% deoxycholate, 1:1,000 protease inhibitor
cocktail P-8340 (Sigma) and 100 mM PMSF. Immunoprecipitation samples were
analysed by immunoblotting using specific primary antibodies for GFP tag
(Invitrogen) and TD-60/RCC2 (Cell Signalling). Anti-rabbit IgG, HRP-linked
antibody (Cell Signalling) was used for ECL detection.
GEF assay. For TD-60 GEF activity, we performed a GDP-release assay as
previously described30,70. In brief, 10mg of each pre-selected GST-tagged GTPase
was added to the following mixture (125 mM EDTA, 50mM HEPES-NaOH pH 6.8,
10mM Mg-GDP, 0.1mgml 1 bovine serum albumin), plus 5 mCi [3H]-GDP
(10mCiml 1; 5,000 Cimmol 1) in a total volume of 200ml. This mixture was
incubated for 15min at 30 C to load the selected GTPases with the radioactive
probe. After adding 20ml of 10mM Mg-GTP, the loading reaction was split into
two tubes (110 ml each), and was then incubated, respectively, with 10 nM
SBP-tagged recombinant TD-60 or a buffer control. After  /þGEF samples were
incubated for 20min at 30 C, 2.5 ml was taken for a specific activity measurement.
The remainder was split into two tubes and bound to 20 ml glutathione sepharose
beads diluted in 500 ml of ice-cold GEF assay buffer for 1 h at 4 C. After four
washes with 500 ml of ice-cold GEF assay buffer, beads were transferred into 4ml of
scintillation fluid for counting. The total amount of nucleotide exchange was
calculated as pmoles of GDP released.
Cellular RalA activity assay. RalA-GTP levels were measured in HeLa cells using
the RalA G-LISA kit (Cytoskeleton) according to the manufacturer’s protocol.
RalA-GTP was detected by using specific primary RalA antibody provided in the
kit. Lysates were tested at a concentration of B0.5mgml 1.
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